Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies
Purpose Utilization of stereotactic body radiation therapy (SBRT) for treatment of localized
prostate cancer is increasing. Guidelines and payers variably support the use of prostate …
prostate cancer is increasing. Guidelines and payers variably support the use of prostate …
Real-time intrafraction motion monitoring in external beam radiotherapy
Radiotherapy (RT) aims to deliver a spatially conformal dose of radiation to tumours while
maximizing the dose sparing to healthy tissues. However, the internal patient anatomy is …
maximizing the dose sparing to healthy tissues. However, the internal patient anatomy is …
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 …
A Widmark, A Gunnlaugsson, L Beckman… - The Lancet, 2019 - thelancet.com
Background Hypofractionated radiotherapy for prostate cancer has gained increased
attention due to its proposed high radiation-fraction sensitivity. Recent reports from studies …
attention due to its proposed high radiation-fraction sensitivity. Recent reports from studies …
Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer
AU Kishan, A Dang, AJ Katz, CA Mantz… - JAMA network …, 2019 - jamanetwork.com
Importance Stereotactic body radiotherapy harnesses improvements in technology to allow
the completion of a course of external beam radiotherapy treatment for prostate cancer in the …
the completion of a course of external beam radiotherapy treatment for prostate cancer in the …
[HTML][HTML] Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials
CR King, D Freeman, I Kaplan, D Fuller… - Radiotherapy and …, 2013 - Elsevier
Purpose The effectiveness of stereotactic body radiotherapy (SBRT) for localized prostate
cancer is tested. Methods and materials A total of 1100 patients with clinically localized …
cancer is tested. Methods and materials A total of 1100 patients with clinically localized …
Hypofractionated radiation therapy for localized prostate cancer: an ASTRO, ASCO, and AUA evidence-based guideline
Background External beam radiation therapy (EBRT) is a standard definitive treatment
option for men with localized prostate cancer and confers long-term prostate cancer control …
option for men with localized prostate cancer and confers long-term prostate cancer control …
[HTML][HTML] Magnetic resonance imaging-guided adaptive radiation therapy: a “game changer” for prostate treatment?
AU Pathmanathan, NJ van As, LGW Kerkmeijer… - International Journal of …, 2018 - Elsevier
Radiation therapy to the prostate involves increasingly sophisticated delivery techniques
and changing fractionation schedules. With a low estimated α/β ratio, a larger dose per …
and changing fractionation schedules. With a low estimated α/β ratio, a larger dose per …
Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
LN Chen, S Suy, S Uhm, EK Oermann, AW Ju… - Radiation …, 2013 - Springer
Background Stereotactic body radiation therapy (SBRT) delivers fewer high-dose fractions of
radiation which may be radiobiologically favorable to conventional low-dose fractions …
radiation which may be radiobiologically favorable to conventional low-dose fractions …
Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer
DWN Kim, LC Cho, C Straka, A Christie, Y Lotan… - International Journal of …, 2014 - Elsevier
Purpose To convey the occurrence of isolated cases of severe rectal toxicity at the highest
dose level tested in 5-fraction stereotactic body radiation therapy (SBRT) for localized …
dose level tested in 5-fraction stereotactic body radiation therapy (SBRT) for localized …
Stereotactic body radiation therapy for low and intermediate risk prostate cancer—Results from a multi-institutional clinical trial
R Hannan, V Tumati, XJ Xie, LC Cho… - European Journal of …, 2016 - Elsevier
Background We report the outcome of a phase I/II clinical trial of stereotactic body radiation
therapy (SBRT) for low (LR) and select intermediate risk (IR) prostate cancer (PCa) patients …
therapy (SBRT) for low (LR) and select intermediate risk (IR) prostate cancer (PCa) patients …